The flow cytometry core has created a one of its kind nanoparticle characterization facility. Check out all the new equipment to assist with characterizing your particles.
The Vega Laboratory for Translational Surgical Neuro-Oncology (VL-TSNO) was proud to represent at the 2025 Congress of Neurological Surgeons (CNS) Annual Meeting in Los Angeles, CA, with multiple invited and podium presentations highlighting our team’s ongoing efforts to advance brain tumor care...
This past weekend, members of the Cardiovascular Imaging Section made their way to Nashville, Tennesse to present at the American Society of Echocardiography 2025. Research student Christy Zheng presented her SEER-Medicare analysis, assessing the variability in echocardiographic surveillance in...
The Health Policy Section had two presentations at the ESC Congress 2025 in Madrid from August 29-September 1st. Jingyi Gong, MD presented her work "Blood pressure, glycemic, and cholesterol...
CytoFLEX mosaic attaches manually to CytoFLEX LX analyzer. Configuration CytoFLEX mosaic 88 for CytoFLEX LX (88 channels of detection) The pattern of fluorescence channels of detection are: U20, V20, B16, Y12, R10, IR3 for CytoFLEX mosaic 88 + CytoFLEX LX UV SSC on each laser to expand the...
A recent Cell publication by Drs. Samuel Vidal and Dan Barouch describes a next-generation mRNA-based tuberculosis (TB) vaccine that surpassed the performance of the century-old BCG vaccine in preclinical studies. The trivalent mRNA–lipid nanoparticle (LNP) vaccine, which combines three newly...
The Vega Laboratory for Translational Surgical Neuro-Oncology (VL-TSNO) is excited to attend the 30th Annual Meeting of the Society for Neuro-Oncology (SNO) in Honolulu, Hawaii this November! This year marks a special milestone for the SNO community, bringing together clinicians, scientists, and...